Key statistics
On Tuesday, Telix Pharmaceuticals Ltd (T3X:BER) closed at 12.70, -2.68% below its 52-week high of 13.05, set on Oct 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.60 |
---|---|
High | 12.70 |
Low | 12.60 |
Bid | 12.37 |
Offer | 13.00 |
Previous close | 12.43 |
Average volume | 2.31k |
---|---|
Shares outstanding | 334.68m |
Free float | 248.60m |
P/E (TTM) | 136.87 |
Market cap | 6.86bn AUD |
EPS (TTM) | 0.1497 AUD |
Data delayed at least 15 minutes, as of Oct 08 2024 17:34 BST.
More ▼
Press releases
- Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
- 'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
- IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
- Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
- Telix Announces Reorganisation to Deliver on Strategic Priorities
- Telix Successfully Prices A$650 Million Convertible Bonds
- Telix Announces A$600 Million Convertible Bonds Offering
More ▼